A chimeric protein comprising an IGF1 and an IGF2 component and optionally a fusion component (F) and/or a signal sequence, exhibiting improved activity relative to the native IGF1 or IGF2 polypeptide. The fusion component (F) may be a multimerizing component, a targeting ligand, or another active or therapeutic compound.

 
Web www.patentalert.com

< Aminated isoflavonoid derivatives and uses thereof

< Substituted biphenyl-4-carboxylic acid arylamide analogues

> Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses

> Furan or thiopene derivative and medicinal use thereof
~ 00292